Cargando…

Recovery of Bone Marrow Function in VEXAS Syndrome-potential Role for Romiplostim

Detalles Bibliográficos
Autores principales:	Al-Hakim, Adam, Cull, Alyssa, Topping, Joanna, Nadat, Fatima, Milek, Joanna, Alhefzi, Razan, McDermott, Michael F., Owen, Roger, Cargo, Catherine, Poulter, James, Kent, David G., Savic, Sinisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374182/ https://www.ncbi.nlm.nih.gov/pubmed/37520777 http://dx.doi.org/10.1097/HS9.0000000000000934

Ejemplares similares

Novel somatic mutations in UBA1 as a cause of VEXAS syndrome
por: Poulter, James A., et al.
Publicado: (2021)

An Atypical Autoinflammatory Disease Due to an LRR Domain NLRP3 Mutation Enhancing Binding to NEK7
por: Caseley, Emily A., et al.
Publicado: (2021)

VEXAS syndrome
por: Grayson, Peter C., et al.
Publicado: (2021)

VEXAS-Syndrom
por: Zeeck, M., et al.
Publicado: (2022)

Thrombosis in VEXAS syndrome
por: Oo, Thet Mon, et al.
Publicado: (2021)

VEXAS Syndrome—Review
por: Zhang, Yue, et al.
Publicado: (2023)

Azacytidine Treatment for VEXAS Syndrome
por: Raaijmakers, Marc H. G. P., et al.
Publicado: (2021)

VEXAS syndrome with cutaneous nodules
por: Argobi, Yahya
Publicado: (2021)

Use of flow cytometric light scattering to recognize the characteristic vacuolated marrow cells in VEXAS syndrome
por: Ding, Yanna, et al.
Publicado: (2023)

A case of VEXAS syndrome presenting with unusual bone marrow granulomas: a diagnostic dilemma
por: Vu, Khiem T., et al.
Publicado: (2023)

VEXAS syndrome: a diagnostic puzzle
por: Ruffer, Nikolas, et al.
Publicado: (2023)

SARS-CoV-2 diagnostics: Towards a more comprehensive approach to routine patient testing
por: Carter, Clive, et al.
Publicado: (2021)

Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune Thrombocytopenia
por: Chandrakala, S., et al.
Publicado: (2022)

Correction to: Efficacy and Safety of Biosimilar Romiplostim Versus Innovator Romiplostim in Patients with Chronic Immune Thrombocytopenia
por: Chandrakala, S., et al.
Publicado: (2023)

VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder
por: Huang, Huijun, et al.
Publicado: (2021)

VEXAS Syndrome: A Novelty in MDS Landscape
por: Templé, Marie, et al.
Publicado: (2022)

VEXAS Syndrome in a Patient with Myeloproliferative Neoplasia
por: Austestad, Janne, et al.
Publicado: (2023)

Intrapatient competition of VEXAS syndrome and CML clones
por: Djerbi, Nadia, et al.
Publicado: (2023)

Identification of a novel MAGT1 mutation supports a diagnosis of XMEN disease
por: Watson, Christopher M., et al.
Publicado: (2022)

Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL-1 Trap)
por: Church, Leigh D, et al.
Publicado: (2008)

Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia
por: Soff, Gerald A., et al.
Publicado: (2019)

Vexas: A new syndrome not always associated with hemopathy
por: Thomas, Benoît, et al.
Publicado: (2021)

Vasculitis associated with VEXAS syndrome: A literature review
por: Watanabe, Ryu, et al.
Publicado: (2022)

Quantitative Assessment of Vacuolization of Myeloid Precursors in VEXAS Syndrome
por: Rabut, Audrey, et al.
Publicado: (2023)

Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome
por: Vitale, Antonio, et al.
Publicado: (2022)

Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia
por: Janssens, Ann, et al.
Publicado: (2016)

The role of romiplostim for pediatric patients with immune thrombocytopenia
por: Al-Samkari, Hanny, et al.
Publicado: (2020)

Quality by Design in Downstream Process Development of Romiplostim
por: Pouri, Saeedeh, et al.
Publicado: (2022)

Romiplostim use in pregnant women with immune thrombocytopenia
por: Bussel, James B., et al.
Publicado: (2022)

Distinction between clonal and paraclonal cutaneous involvements in VEXAS syndrome
por: Lacombe, Valentin, et al.
Publicado: (2022)

VEXAS syndrome: a newly discovered systemic rheumatic disorder
por: Kucharz, Eugenisz J.
Publicado: (2023)

Recurrent superior orbital fissure syndrome associated with VEXAS syndrome
por: Myint, Katie, et al.
Publicado: (2023)

Identification of Critical Transcriptomic Signaling Pathways in Patients with H Syndrome and Rosai-Dorfman Disease
por: Lara-Reyna, Samuel, et al.
Publicado: (2020)

Participant views on participating in a pragmatic randomised controlled trial: the Aboriginal and Torres Strait Islander Women’s Fitness Program
por: Canuto, Karla, et al.
Publicado: (2014)

A randomized, double‐blind, comparative study of the pharmacodynamics and pharmacokinetics of GP40141 (romiplostim biosimilar) and reference romiplostim in healthy male volunteers
por: Makarenko, Igor, et al.
Publicado: (2023)

Myelodysplastic Syndrome Associated With Auto-Immune Inflammatory Disease in VEXAS Syndrome
por: Thomas, Vibha Taneja, et al.
Publicado: (2021)

Case Report: Coexistence of Multiple Myeloma and Auricular Chondritis in VEXAS Syndrome
por: Matsumoto, Haruki, et al.
Publicado: (2022)

Venous inflammation might be one of the features of VEXAS syndrome and associated thrombosis
por: Karadeniz, Hazan, et al.
Publicado: (2023)

Romiplostim as early treatment of immune thrombocytopenia with severe immunodeficiency
por: Palandri, Francesca, et al.
Publicado: (2012)

Assessment of immunogenicity of romiplostim in clinical studies with ITP subjects
por: Jawa, Vibha, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_1j6u68j32kgn101q820336gv46